![Zoran Zdraveski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zoran Zdraveski
Algemeen Adviseur bij
TSCAN THERAPEUTICS, INC.
Vermogen: 3 443 $ op 31-08-2026
Profiel
Zoran Zdraveski is currently Secretary, Chief Legal & Strategy Officer at TScan Therapeutics, Inc. since 2021.
Formerly, Dr. Zdraveski was Vice President & Associate General Counsel at Epizyme, Inc. from 2012 to 2017 and Secretary & Chief Legal Officer at Magenta Therapeutics, Inc. from 2017 to 2021.
Education includes undergraduate and graduate degrees from Southern Methodist University, a graduate degree from Suffolk University Law School conferred in 2007, and a doctorate from the Massachusetts Institute of Technology conferred in 2002.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-01-2026 | 4.716 ( 0,01% ) | 3 443 $ | 31-08-2026 |
Actieve functies van Zoran Zdraveski
| Bedrijven | Functie | Begin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Algemeen Adviseur | 09-09-2021 |
Eerdere bekende functies van Zoran Zdraveski
| Bedrijven | Functie | Einde |
|---|---|---|
| MAGENTA THERAPEUTICS | Algemeen Adviseur | 01-04-2021 |
| EPIZYME, INC. | Corporate Officer/Principal | 01-04-2017 |
Opleiding van Zoran Zdraveski
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
83
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
